Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
01/02/1992 | EP0463157A1 Lfa-3 as a vaccine adjuvant |
01/02/1992 | EP0463115A1 Acetylated heterologous polypeptides. |
01/02/1992 | EP0463110A1 Monoclonal antibodies for metallic cations |
01/02/1992 | EP0463082A1 Purified ciliary neurotrophic factor |
01/02/1992 | EP0463081A1 Hormone response element compositions and assay |
01/02/1992 | EP0463080A1 Cd8-based pharmaceuticals |
01/02/1992 | EP0463072A1 Novel insulin compounds. |
01/02/1992 | EP0463064A1 Neuronal nicotinic acetylcholine receptor compositions containing the beta4 subunit |
01/02/1992 | EP0463059A1 Allergenic proteins from ragweed and uses therefor |
01/02/1992 | EP0463056A1 External regulation of gene expression |
01/02/1992 | EP0463053A1 Production and use of anthelmintic agents and protective immunogens |
01/02/1992 | EP0463037A1 Human macrophage migration inhibitory factor |
01/02/1992 | EP0255823B1 Dna encoding adasp?113 bd and adlys?46 , asp?113 bd thaumatin i |
01/02/1992 | EP0196319B1 Retroviral polypeptides associated with human cellular transformation |
01/02/1992 | EP0189431B1 Process for purifying a protein |
01/02/1992 | EP0179152B1 Diagnostic system for the detection of cytomegalovirus |
01/02/1992 | DE4020181A1 Neue promotorregion Last promoter region |
12/31/1991 | WO1992000328A1 Non-a non-b sequences |
12/31/1991 | US5077393 Binding to immobilized glycosaminoglycans in presence of prote in denaturing agent |
12/31/1991 | US5077392 Process for activation of recombinant protein produced by prokaryotes |
12/31/1991 | US5077390 Cationic and anionic exchange chromatography |
12/31/1991 | US5077388 Purification of human interleukin-4 from a secreted escherichia coli mutant |
12/31/1991 | US5077285 Imidazole compounds and their use as transglutaminase inhibitors |
12/31/1991 | US5077276 Growth factor |
12/31/1991 | US5077219 Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins |
12/31/1991 | US5077213 Recombinant vaccinia virus |
12/31/1991 | US5077209 Dicarboxylic acid transport genes |
12/31/1991 | US5077204 Yeast endopeptidase for basic amino-acid site cleavage, preparation and use |
12/31/1991 | US5077195 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
12/31/1991 | US5077193 Diagnostic kits |
12/31/1991 | US5077044 Prevention bacillary dysentery |
12/31/1991 | CA2072092A1 Non-a non-b sequences |
12/31/1991 | CA1293840C Renin inhibiting polypeptide analogs and intermediates |
12/31/1991 | CA1293839C Process for obtention of peptide amino-alcohol derivatives containing a tetrasubstituted carbon as inhibiting agents of renin and acid proteases |
12/30/1991 | WO1992000373A1 Melanin production by transformed microorganisms |
12/30/1991 | WO1992000095A1 Histidine substituted growth hormone releasing factor analogs |
12/30/1991 | CA2085362A1 Histidine substituted growth hormone releasing factor analogs |
12/30/1991 | CA2045876A1 Immunological detection methods |
12/29/1991 | WO1992000375A1 Sex determining gene |
12/29/1991 | CA2085102A1 Sex determining gene |
12/28/1991 | WO1992000099A1 Method of introducing a peptide into the cytosol |
12/28/1991 | CA2086342A1 Method of introducing a peptide into a cytosol |
12/28/1991 | CA2058041A1 Anti-igf-ii monoclonal antibody |
12/27/1991 | WO1992000080A1 Method for treating leukemias |
12/27/1991 | EP0462792A2 Process for obtaining cellular protein having anti-HIV activity |
12/27/1991 | EP0462721A2 Novel Bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from Bacillus thuringiensis isolates |
12/27/1991 | EP0462674A1 An oxido reductase enzyme system obtainable from P. chrysogenum, the set of genes encoding the same and the use of oxido reductase enzyme systems or genes encoding the same for increasing antibiotic production |
12/27/1991 | EP0462669A2 Amine enriched proteins |
12/27/1991 | EP0462632A1 Method for producing a desired human protein by recombinant DNA techniques |
12/27/1991 | EP0462627A1 Antigens and peptides of lav. |
12/27/1991 | EP0462623A1 Monoclonal antibodies to human immune interferon |
12/27/1991 | EP0462549A1 Process of preparing a therapeutic agent for renal diseases |
12/27/1991 | EP0462534A2 Acellular anti-pertussis vaccines |
12/27/1991 | EP0462398A1 TGF-beta compositions |
12/27/1991 | EP0462305A1 Aerosol containing cytokines and use thereof |
12/27/1991 | EP0462277A1 Glycoprotein of human origin, physiologically active factor comprising the same, and pharmaceutical preparation containing the same as active ingredient |
12/27/1991 | EP0462246A1 Oligomeric immunoglobulins |
12/27/1991 | EP0462231A1 Transcriptional activators of anthocyanin biosynthesis as visual markers for plant transformation |
12/27/1991 | EP0462229A1 Chemically modified cd4 peptide fragments having anti-retroviral properties |
12/27/1991 | EP0462215A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
12/27/1991 | EP0462207A1 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
12/27/1991 | EP0462205A1 Leukocyte adhesion receptors |
12/27/1991 | EP0462192A1 Glycosylated insulins |
12/27/1991 | EP0462184A1 Method of treating viral infections using lfa-1 |
12/27/1991 | EP0462177A1 Purified insulin mediators and purification process for same |
12/27/1991 | EP0462147A1 Monoclonal antibodies to synthetic pyrethroids and method for detecting the same |
12/27/1991 | EP0462111A1 Homing sequences and their uses |
12/27/1991 | CA2086105A1 Method for treating leukemias |
12/27/1991 | CA2045420A1 Peptides having atrial natriuretic factor activity |
12/26/1991 | WO1992000318A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
12/26/1991 | WO1992000017A1 Method and device for obtaining beta casein |
12/26/1991 | WO1991019982A1 Determination of polypeptides and proteins in solutions and biological fluids |
12/26/1991 | WO1991019813A1 Nucleic acid ligands |
12/26/1991 | WO1991019810A1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
12/26/1991 | WO1991019803A1 Self assembled, defective, nonself-propagating viral particles |
12/26/1991 | WO1991019801A1 RECOMBINANT 47 AND 31kD COCOA PROTEINS AND PRECURSOR |
12/26/1991 | WO1991019800A1 RECOMBINANT 21 kD COCOA PROTEIN AND PRECURSOR |
12/26/1991 | WO1991019797A1 Heterohybridomas producing human monoclonal antibodies to hiv-1 |
12/26/1991 | WO1991019788A1 An oxido reductase enzyme system obtainable from p. chrysogenum, the set of genes encoding the same and the use of oxido reductase enzyme systems or genes encoding the same for increasing antibiotic production |
12/26/1991 | WO1991019787A1 Protease nexin-i variants |
12/26/1991 | WO1991019785A1 THE RETROVIRUS SIVcpz-ant AND ITS USES |
12/26/1991 | WO1991019784A1 A Lac REPRESSOR-HSV VP16 CHIMERIC TRANSCRIPTIONAL ACTIVATOR PROTEIN SYSTEM FUNCTIONING IN TRANSFECTED MAMMALIAN CELLS |
12/26/1991 | WO1991019770A1 Fungal adhesive and process of purification |
12/26/1991 | WO1991019744A1 Hepatitis c virus antigen polypeptide, production thereof, and detection of antibody |
12/26/1991 | WO1991019743A2 COMBINED TREATMENT WITH GnRH ANTAGONIST AND GnRH TO CONTROL GONADOTROPIN LEVELS IN MAMMALS |
12/26/1991 | WO1991019741A1 Albumin binding proteins |
12/26/1991 | WO1991019740A1 IgG-BINDING PROTEIN |
12/26/1991 | WO1991019734A2 Thrombin inhibitors based on the amino acid sequence of hirudin |
12/26/1991 | WO1991019733A1 Derivatives of tetrapeptides as cck agonists |
12/26/1991 | WO1991019513A1 METHODS OF MODULATING BLOOD PRESSURE USING TGF-β AND ANTAGONISTS THEREOF |
12/26/1991 | WO1991019511A1 CONTROLLING CELLULAR IMMUNE/INFLAMMATORY RESPONSES WITH β2 INTEGRINS |
12/26/1991 | WO1991019505A1 Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin |
12/26/1991 | WO1991019419A1 Pasteurella multocida toxoid vaccines |
12/26/1991 | WO1991017773A3 New protein-polycation conjugates |
12/26/1991 | WO1991017187A3 A 35kd tumor associated protein antigen: uses and methods of detection |
12/26/1991 | CA2086006A1 Device and process for obtaining caseine beta |
12/26/1991 | CA2085980A1 Protease nexin-i variants |
12/26/1991 | CA2085370A1 The retrovirus siv cpz-ant and its uses |
12/26/1991 | CA2084992A1 Tissue-derived tumor growth inhibitors, methods for preparation and uses thereof |
12/26/1991 | CA2084059A1 Recombinant 47 and 31kd cocoa proteins and precursor |